Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Income taxes - Schedule of Deferred Tax Assets And Liabilities (Details)

v3.22.1
Income taxes - Schedule of Deferred Tax Assets And Liabilities (Details) - USD ($)
$ in Thousands
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Deferred tax assets:      
Net operating loss carryforwards $ 41,699 $ 29,824 $ 25,632
Research and development expenses and other 7,995 4,817 4,348
Accruals and reserves 1,553 1,068 557
Share-based compensation 669 265 119
Issuance costs 2,368 0 0
Other 97 0 0
Gross deferred tax assets 54,381 35,974 30,656
Valuation allowance (51,417) (34,266) (29,983)
Deferred Tax Assets, Net of Valuation Allowance, Total 2,964 1,708 673
Total deferred tax assets      
Deferred tax liabilities: (3,342) 0 0
Intangible assets (2,269) (2,012) (736)
Deferred contract acquisition costs (212) (129) (121)
Property and equipment 0 (18) (19)
Other (5,823) (2,159) (876)
Gross deferred tax liabilities $ (2,859) $ (451) $ (203)